Key result
Actin H40Y mutation severely disrupts filament structure, creating stiff filaments that prevent proper myosin binding.
Why the study?
The molecular mechanisms by which ACTA1 gene mutations cause muscle weakness and myopathies remain obscure.
The H40Y mutation in ACTA1 causes myopathy by disrupting actin filament structure and impairing myosin binding.
Answers are grounded in this paper and cite their sources.
May inform targeted ACTA1 therapies; leaves open clinical validation of mechanistic findings.
In humans, more than 200 missense mutations have been identified in the ACTA1 gene. The exact molecular mechanisms by which, these particular mutations become toxic and lead to muscle weakness and myopathies remain obscure. To address this, here, we performed a molecular dynamics simulation, and we used a broad range of biophysical assays to determine how the lethal and myopathy-related H40Y amino acid substitution in actin affects the structure, stability, and function of this protein. Interestingly, our results showed that H40Y severely disrupts the DNase I-binding-loop structure and actin filaments. In addition, we observed that normal and mutant actin monomers are likely to form distinctive homopolymers, with mutant filaments being very stiff, and not supporting proper myosin binding. These phenomena underlie the toxicity of H40Y and may be considered as important triggering factors for the contractile dysfunction, muscle weakness and disease phenotype seen in patients.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2016) studied Myopathy and muscle weakness. H40Y amino acid substitution in actin vs. Normal actin monomers was evaluated on Structure, stability, and function of actin protein. The H40Y mutation in actin severely disrupts the DNase I-binding-loop structure and actin filaments, resulting in stiff mutant filaments that do not support proper myosin binding.
Synapse has enriched 10 related papers. Consider them for comparative context: